ID   HXK2_HUMAN              Reviewed;         917 AA.
AC   P52789; D6W5J2; Q8WU87; Q9UN82;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 2.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=Hexokinase-2;
DE            EC=2.7.1.1;
DE   AltName: Full=Hexokinase type II;
DE            Short=HK II;
DE   AltName: Full=Muscle form hexokinase;
GN   Name=HK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=8250948; DOI=10.1006/bbrc.1993.2442;
RA   Deeb S.S., Malkki M., Laakso M.;
RT   "Human hexokinase II: sequence and homology to other hexokinases.";
RL   Biochem. Biophys. Res. Commun. 197:68-74(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-142.
RC   TISSUE=Blood, Muscle, and Placenta;
RX   PubMed=8786021; DOI=10.1007/BF00400608;
RA   Lehto M., Huang X., Davis E.M., Le Beau M.M., Laurila E.,
RA   Eriksson K.F., Bell G.I., Groop L.C.;
RT   "Human hexokinase II gene: exon-intron organization, mutation
RT   screening in NIDDM, and its relationship to muscle hexokinase
RT   activity.";
RL   Diabetologia 38:1466-1474(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RA   Malkki M., Heikkinen S., Deeb S.S., Laakso M.;
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-142; CYS-274;
RP   PRO-314; ILE-331; SER-387; GLN-801; LYS-844 AND ASN-881.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 614-739.
RX   PubMed=7518342; DOI=10.1016/0304-3835(94)90142-2;
RA   Shinohara Y., Yamamoto K., Kogure K., Ichihara J., Terada H.;
RT   "Steady state transcript levels of the type II hexokinase and type 1
RT   glucose transporter in human tumor cell lines.";
RL   Cancer Lett. 82:27-32(1994).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   INTERACTION WITH TIGAR.
RX   PubMed=23185017; DOI=10.1073/pnas.1206530109;
RA   Cheung E.C., Ludwig R.L., Vousden K.H.;
RT   "Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and
RT   lowers ROS and cell death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:20491-20496(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 17-916 IN COMPLEX WITH
RP   GLUCOSE AND GLUCOSE-6-PHOSPHATE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human hexokinase II.";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [12]
RP   VARIANTS VAL-314; CYS-353 AND GLN-775.
RX   PubMed=7883120; DOI=10.2337/diab.44.3.330;
RA   Laakso M., Malkki M., Deeb S.S.;
RT   "Amino acid substitutions in hexokinase II among patients with
RT   NIDDM.";
RL   Diabetes 44:330-334(1995).
RN   [13]
RP   VARIANT HIS-142.
RX   PubMed=7883122; DOI=10.2337/diab.44.3.340;
RA   Vidal-Puig A., Printz R.L., Stratton I.M., Granner D.K., Moller D.E.;
RT   "Analysis of the hexokinase II gene in subjects with insulin
RT   resistance and NIDDM and detection of a Gln142-->His substitution.";
RL   Diabetes 44:340-346(1995).
RN   [14]
RP   VARIANTS HIS-142; PHE-148; GLN-497 AND LYS-844.
RX   PubMed=7883123; DOI=10.2337/diab.44.3.347;
RA   Echwald S.M., Bjoerbaek C., Hansen T., Clausen J.O., Vestergaard H.,
RA   Zierath J.R., Printz R.L., Granner D.K., Pedersen O.;
RT   "Identification of four amino acid substitutions in hexokinase II and
RT   studies of relationships to NIDDM, glucose effectiveness, and insulin
RT   sensitivity.";
RL   Diabetes 44:347-353(1995).
CC   -!- CATALYTIC ACTIVITY: ATP + D-hexose = ADP + D-hexose 6-phosphate.
CC   -!- ENZYME REGULATION: Hexokinase is an allosteric enzyme inhibited by
CC       its product Glc-6-P.
CC   -!- PATHWAY: Carbohydrate metabolism; hexose metabolism.
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with TIGAR; the
CC       interaction increases hexokinase HK2 activity in a hypoxia- and
CC       HIF1A-dependent manner (PubMed:23185017).
CC       {ECO:0000250|UniProtKB:P35557, ECO:0000269|PubMed:23185017}.
CC   -!- INTERACTION:
CC       Q6FHH8:MAGEA12; NbExp=3; IntAct=EBI-741469, EBI-10178394;
CC       Q9UMX0:UBQLN1; NbExp=4; IntAct=EBI-741469, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-741469, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}.
CC       Note=Its hydrophobic N-terminal sequence may be involved in
CC       membrane binding. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Predominant hexokinase isozyme expressed in
CC       insulin-responsive tissues such as skeletal muscle.
CC   -!- DOMAIN: The N- and C-terminal halves of this hexokinase show
CC       extensive sequence similarity to each other. The catalytic
CC       activity is associated with the C-terminus while regulatory
CC       function is associated with the N-terminus. Each domain can bind a
CC       single glucose and Gluc-6-P molecule.
CC   -!- POLYMORPHISM: Although found in NIDDM patients, genetic variations
CC       of HK2 do not contribute to the disease (PubMed:7883122,
CC       PubMed:7883123). {ECO:0000269|PubMed:7883122,
CC       ECO:0000269|PubMed:7883123}.
CC   -!- MISCELLANEOUS: In vertebrates there are four major glucose-
CC       phosphorylating isoenzymes, designated hexokinase I, II, III and
CC       IV (glucokinase).
CC   -!- SIMILARITY: Belongs to the hexokinase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01084, ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hk2/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hexokinase entry;
CC       URL="https://en.wikipedia.org/wiki/Hexokinase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z46376; CAA86511.1; -; mRNA.
DR   EMBL; Z46354; CAA86476.2; -; Genomic_DNA.
DR   EMBL; Z46355; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46604; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46356; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46357; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46358; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46359; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46360; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46361; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46362; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46363; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46364; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46365; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46366; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46367; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46368; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; Z46369; CAA86476.2; JOINED; Genomic_DNA.
DR   EMBL; AF148513; AAD30174.1; -; mRNA.
DR   EMBL; AY623118; AAT38114.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99601.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99602.1; -; Genomic_DNA.
DR   EMBL; BC021116; AAH21116.1; -; mRNA.
DR   EMBL; BC064369; AAH64369.1; -; mRNA.
DR   EMBL; D25412; BAA04999.1; -; Genomic_DNA.
DR   CCDS; CCDS1956.1; -.
DR   PIR; S48809; JC2025.
DR   RefSeq; NP_000180.2; NM_000189.4.
DR   UniGene; Hs.406266; -.
DR   UniGene; Hs.591588; -.
DR   PDB; 2NZT; X-ray; 2.45 A; A/B=17-916.
DR   PDB; 5HEX; X-ray; 2.73 A; A/B=17-917.
DR   PDB; 5HFU; X-ray; 2.92 A; A/B=17-917.
DR   PDB; 5HG1; X-ray; 2.76 A; A=17-916.
DR   PDBsum; 2NZT; -.
DR   PDBsum; 5HEX; -.
DR   PDBsum; 5HFU; -.
DR   PDBsum; 5HG1; -.
DR   ProteinModelPortal; P52789; -.
DR   SMR; P52789; -.
DR   BioGrid; 109346; 46.
DR   DIP; DIP-50110N; -.
DR   IntAct; P52789; 14.
DR   MINT; MINT-1461614; -.
DR   STRING; 9606.ENSP00000290573; -.
DR   BindingDB; P52789; -.
DR   ChEMBL; CHEMBL2640; -.
DR   iPTMnet; P52789; -.
DR   PhosphoSitePlus; P52789; -.
DR   SwissPalm; P52789; -.
DR   BioMuta; HK2; -.
DR   DMDM; 56405344; -.
DR   EPD; P52789; -.
DR   MaxQB; P52789; -.
DR   PaxDb; P52789; -.
DR   PeptideAtlas; P52789; -.
DR   PRIDE; P52789; -.
DR   DNASU; 3099; -.
DR   Ensembl; ENST00000290573; ENSP00000290573; ENSG00000159399.
DR   GeneID; 3099; -.
DR   KEGG; hsa:3099; -.
DR   UCSC; uc002snd.4; human.
DR   CTD; 3099; -.
DR   DisGeNET; 3099; -.
DR   GeneCards; HK2; -.
DR   H-InvDB; HIX0030207; -.
DR   HGNC; HGNC:4923; HK2.
DR   HPA; HPA028587; -.
DR   MIM; 601125; gene.
DR   neXtProt; NX_P52789; -.
DR   OpenTargets; ENSG00000159399; -.
DR   PharmGKB; PA29301; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   GeneTree; ENSGT00390000017159; -.
DR   HOGENOM; HOG000162671; -.
DR   HOVERGEN; HBG005020; -.
DR   InParanoid; P52789; -.
DR   KO; K00844; -.
DR   OMA; HHLGLES; -.
DR   OrthoDB; EOG091G08MD; -.
DR   PhylomeDB; P52789; -.
DR   TreeFam; TF314238; -.
DR   BioCyc; MetaCyc:HS08399-MONOMER; -.
DR   BRENDA; 2.7.1.1; 2681.
DR   Reactome; R-HSA-70153; Glucose transport.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   SABIO-RK; P52789; -.
DR   UniPathway; UPA00242; -.
DR   ChiTaRS; HK2; human.
DR   EvolutionaryTrace; P52789; -.
DR   GeneWiki; HK2; -.
DR   GenomeRNAi; 3099; -.
DR   PRO; PR:P52789; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000159399; -.
DR   CleanEx; HS_HK2; -.
DR   ExpressionAtlas; P52789; baseline and differential.
DR   Genevisible; P52789; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008865; F:fructokinase activity; IBA:GO_Central.
DR   GO; GO:0004340; F:glucokinase activity; IBA:GO_Central.
DR   GO; GO:0005536; F:glucose binding; IEA:Ensembl.
DR   GO; GO:0004396; F:hexokinase activity; TAS:ProtInc.
DR   GO; GO:0019158; F:mannokinase activity; IBA:GO_Central.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; IDA:MGI.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0001678; P:cellular glucose homeostasis; IBA:GO_Central.
DR   GO; GO:0072655; P:establishment of protein localization to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0015758; P:glucose transport; TAS:Reactome.
DR   GO; GO:0006096; P:glycolytic process; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0007595; P:lactation; IEA:Ensembl.
DR   GO; GO:0072656; P:maintenance of protein location in mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0035795; P:negative regulation of mitochondrial membrane permeability; IEA:Ensembl.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:1904925; P:positive regulation of mitophagy in response to mitochondrial depolarization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0046324; P:regulation of glucose import; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; PTHR19443; 1.
DR   Pfam; PF00349; Hexokinase_1; 2.
DR   Pfam; PF03727; Hexokinase_2; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 2.
DR   PROSITE; PS51748; HEXOKINASE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; ATP-binding;
KW   Complete proteome; Glycolysis; Kinase; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Repeat; Transferase.
FT   CHAIN         1    917       Hexokinase-2.
FT                                /FTId=PRO_0000197587.
FT   DOMAIN       16    458       Hexokinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01084}.
FT   DOMAIN      464    906       Hexokinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01084}.
FT   NP_BIND      84     89       ATP 1. {ECO:0000255}.
FT   NP_BIND     425    426       ATP 1. {ECO:0000250}.
FT   NP_BIND     532    537       ATP 2. {ECO:0000250}.
FT   NP_BIND     747    748       ATP 2. {ECO:0000250}.
FT   NP_BIND     784    788       ATP 2. {ECO:0000250}.
FT   NP_BIND     863    867       ATP 2. {ECO:0000250}.
FT   REGION        1     12       Hydrophobic.
FT   REGION       13    475       Regulatory.
FT   REGION       73    207       Hexokinase small subdomain 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION       84     88       Glucose-6-phosphate 1 binding.
FT   REGION      155    156       Substrate 1 binding.
FT   REGION      172    173       Substrate 1 binding.
FT   REGION      208    447       Hexokinase large subdomain 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION      208    209       Substrate 1 binding.
FT   REGION      291    294       Substrate 1 binding.
FT   REGION      413    415       Glucose-6-phosphate 1 binding.
FT   REGION      476    917       Catalytic.
FT   REGION      521    655       Hexokinase small subdomain 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION      532    536       Glucose-6-phosphate 2 binding.
FT   REGION      603    604       Substrate 2 binding.
FT   REGION      620    621       Substrate 2 binding.
FT   REGION      656    895       Hexokinase large subdomain 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION      656    657       Substrate 2 binding.
FT   REGION      682    683       Substrate 2 binding.
FT   REGION      739    742       Substrate 2 binding.
FT   REGION      861    863       Glucose-6-phosphate 2 binding.
FT   BINDING      30     30       ATP 1. {ECO:0000250}.
FT   BINDING     209    209       Glucose-6-phosphate 1.
FT                                {ECO:0000269|Ref.11}.
FT   BINDING     232    232       Glucose-6-phosphate 1.
FT                                {ECO:0000269|Ref.11}.
FT   BINDING     235    235       Substrate 1.
FT   BINDING     260    260       Substrate 1.
FT   BINDING     449    449       Glucose-6-phosphate 1.
FT                                {ECO:0000269|Ref.11}.
FT   BINDING     558    558       ATP. {ECO:0000255}.
FT   BINDING     657    657       Glucose-6-phosphate 2.
FT                                {ECO:0000269|Ref.11}.
FT   BINDING     680    680       ATP 2. {ECO:0000250}.
FT   BINDING     680    680       Glucose-6-phosphate 2.
FT                                {ECO:0000269|Ref.11}.
FT   BINDING     708    708       Substrate 2.
FT   BINDING     897    897       Glucose-6-phosphate 2.
FT                                {ECO:0000269|Ref.11}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   VARIANT     142    142       Q -> H (does not affect activity;
FT                                dbSNP:rs2229621).
FT                                {ECO:0000269|PubMed:7883122,
FT                                ECO:0000269|PubMed:7883123,
FT                                ECO:0000269|PubMed:8786021,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_003691.
FT   VARIANT     148    148       L -> F. {ECO:0000269|PubMed:7883123}.
FT                                /FTId=VAR_010577.
FT   VARIANT     274    274       R -> C (in dbSNP:rs28363006).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020504.
FT   VARIANT     314    314       A -> P (in dbSNP:rs28363015).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020505.
FT   VARIANT     314    314       A -> V. {ECO:0000269|PubMed:7883120}.
FT                                /FTId=VAR_010578.
FT   VARIANT     331    331       T -> I (in dbSNP:rs28363016).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020506.
FT   VARIANT     353    353       R -> C (in dbSNP:rs61748096).
FT                                {ECO:0000269|PubMed:7883120}.
FT                                /FTId=VAR_010579.
FT   VARIANT     387    387       A -> S (in dbSNP:rs28363029).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020507.
FT   VARIANT     497    497       R -> Q (in dbSNP:rs145124653).
FT                                {ECO:0000269|PubMed:7883123}.
FT                                /FTId=VAR_010580.
FT   VARIANT     775    775       R -> Q (in dbSNP:rs185927605).
FT                                {ECO:0000269|PubMed:7883120}.
FT                                /FTId=VAR_010581.
FT   VARIANT     801    801       R -> Q (in dbSNP:rs28363057).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020508.
FT   VARIANT     844    844       R -> K (in dbSNP:rs2229629).
FT                                {ECO:0000269|PubMed:7883123,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_010582.
FT   VARIANT     881    881       D -> N (in dbSNP:rs28363065).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020509.
FT   CONFLICT    803    803       I -> T (in Ref. 1; CAA86511).
FT                                {ECO:0000305}.
FT   CONFLICT    870    870       Missing (in Ref. 2; CAA86476).
FT                                {ECO:0000305}.
FT   HELIX        19     25       {ECO:0000244|PDB:2NZT}.
FT   HELIX        27     29       {ECO:0000244|PDB:2NZT}.
FT   HELIX        33     51       {ECO:0000244|PDB:2NZT}.
FT   TURN         53     55       {ECO:0000244|PDB:2NZT}.
FT   HELIX        56     58       {ECO:0000244|PDB:2NZT}.
FT   STRAND       78     97       {ECO:0000244|PDB:2NZT}.
FT   STRAND      100    102       {ECO:0000244|PDB:5HEX}.
FT   STRAND      106    112       {ECO:0000244|PDB:2NZT}.
FT   HELIX       116    119       {ECO:0000244|PDB:2NZT}.
FT   HELIX       123    141       {ECO:0000244|PDB:2NZT}.
FT   HELIX       143    145       {ECO:0000244|PDB:5HG1}.
FT   STRAND      148    154       {ECO:0000244|PDB:2NZT}.
FT   STRAND      161    164       {ECO:0000244|PDB:5HEX}.
FT   STRAND      165    168       {ECO:0000244|PDB:5HFU}.
FT   HELIX       185    194       {ECO:0000244|PDB:2NZT}.
FT   STRAND      201    207       {ECO:0000244|PDB:2NZT}.
FT   HELIX       209    218       {ECO:0000244|PDB:2NZT}.
FT   STRAND      224    241       {ECO:0000244|PDB:2NZT}.
FT   HELIX       242    244       {ECO:0000244|PDB:2NZT}.
FT   STRAND      252    258       {ECO:0000244|PDB:2NZT}.
FT   HELIX       261    263       {ECO:0000244|PDB:2NZT}.
FT   TURN        264    267       {ECO:0000244|PDB:2NZT}.
FT   TURN        269    273       {ECO:0000244|PDB:2NZT}.
FT   HELIX       276    283       {ECO:0000244|PDB:2NZT}.
FT   STRAND      285    287       {ECO:0000244|PDB:2NZT}.
FT   HELIX       292    295       {ECO:0000244|PDB:2NZT}.
FT   TURN        299    301       {ECO:0000244|PDB:2NZT}.
FT   HELIX       302    315       {ECO:0000244|PDB:2NZT}.
FT   HELIX       320    322       {ECO:0000244|PDB:2NZT}.
FT   HELIX       326    329       {ECO:0000244|PDB:2NZT}.
FT   HELIX       336    344       {ECO:0000244|PDB:2NZT}.
FT   STRAND      345    347       {ECO:0000244|PDB:2NZT}.
FT   HELIX       348    358       {ECO:0000244|PDB:2NZT}.
FT   HELIX       365    401       {ECO:0000244|PDB:2NZT}.
FT   STRAND      404    413       {ECO:0000244|PDB:2NZT}.
FT   HELIX       415    419       {ECO:0000244|PDB:2NZT}.
FT   STRAND      420    422       {ECO:0000244|PDB:2NZT}.
FT   HELIX       423    434       {ECO:0000244|PDB:2NZT}.
FT   STRAND      438    444       {ECO:0000244|PDB:2NZT}.
FT   HELIX       449    474       {ECO:0000244|PDB:2NZT}.
FT   HELIX       475    477       {ECO:0000244|PDB:2NZT}.
FT   HELIX       481    499       {ECO:0000244|PDB:2NZT}.
FT   HELIX       501    504       {ECO:0000244|PDB:2NZT}.
FT   STRAND      527    536       {ECO:0000244|PDB:2NZT}.
FT   STRAND      539    545       {ECO:0000244|PDB:2NZT}.
FT   STRAND      548    550       {ECO:0000244|PDB:5HEX}.
FT   STRAND      553    559       {ECO:0000244|PDB:2NZT}.
FT   HELIX       564    568       {ECO:0000244|PDB:2NZT}.
FT   HELIX       571    588       {ECO:0000244|PDB:2NZT}.
FT   STRAND      597    602       {ECO:0000244|PDB:2NZT}.
FT   STRAND      606    610       {ECO:0000244|PDB:2NZT}.
FT   STRAND      613    616       {ECO:0000244|PDB:2NZT}.
FT   HELIX       633    642       {ECO:0000244|PDB:2NZT}.
FT   STRAND      650    655       {ECO:0000244|PDB:2NZT}.
FT   HELIX       657    666       {ECO:0000244|PDB:2NZT}.
FT   STRAND      672    689       {ECO:0000244|PDB:2NZT}.
FT   TURN        690    692       {ECO:0000244|PDB:2NZT}.
FT   STRAND      699    706       {ECO:0000244|PDB:2NZT}.
FT   HELIX       709    711       {ECO:0000244|PDB:2NZT}.
FT   TURN        712    715       {ECO:0000244|PDB:2NZT}.
FT   TURN        717    721       {ECO:0000244|PDB:2NZT}.
FT   HELIX       724    731       {ECO:0000244|PDB:2NZT}.
FT   STRAND      733    735       {ECO:0000244|PDB:2NZT}.
FT   HELIX       742    744       {ECO:0000244|PDB:2NZT}.
FT   TURN        747    749       {ECO:0000244|PDB:2NZT}.
FT   HELIX       750    763       {ECO:0000244|PDB:2NZT}.
FT   HELIX       768    770       {ECO:0000244|PDB:2NZT}.
FT   TURN        774    776       {ECO:0000244|PDB:2NZT}.
FT   HELIX       785    788       {ECO:0000244|PDB:2NZT}.
FT   TURN        789    791       {ECO:0000244|PDB:2NZT}.
FT   HELIX       797    806       {ECO:0000244|PDB:2NZT}.
FT   HELIX       813    848       {ECO:0000244|PDB:2NZT}.
FT   STRAND      852    861       {ECO:0000244|PDB:2NZT}.
FT   HELIX       863    867       {ECO:0000244|PDB:2NZT}.
FT   STRAND      868    870       {ECO:0000244|PDB:5HG1}.
FT   HELIX       871    882       {ECO:0000244|PDB:2NZT}.
FT   STRAND      886    892       {ECO:0000244|PDB:2NZT}.
FT   HELIX       897    911       {ECO:0000244|PDB:2NZT}.
SQ   SEQUENCE   917 AA;  102380 MW;  F17CE1938CF13880 CRC64;
     MIASHLLAYF FTELNHDQVQ KVDQYLYHMR LSDETLLEIS KRFRKEMEKG LGATTHPTAA
     VKMLPTFVRS TPDGTEHGEF LALDLGGTNF RVLWVKVTDN GLQKVEMENQ IYAIPEDIMR
     GSGTQLFDHI AECLANFMDK LQIKDKKLPL GFTFSFPCHQ TKLDESFLVS WTKGFKSSGV
     EGRDVVALIR KAIQRRGDFD IDIVAVVNDT VGTMMTCGYD DHNCEIGLIV GTGSNACYME
     EMRHIDMVEG DEGRMCINME WGAFGDDGSL NDIRTEFDQE IDMGSLNPGK QLFEKMISGM
     YMGELVRLIL VKMAKEELLF GGKLSPELLN TGRFETKDIS DIEGEKDGIR KAREVLMRLG
     LDPTQEDCVA THRICQIVST RSASLCAATL AAVLQRIKEN KGEERLRSTI GVDGSVYKKH
     PHFAKRLHKT VRRLVPGCDV RFLRSEDGSG KGAAMVTAVA YRLADQHRAR QKTLEHLQLS
     HDQLLEVKRR MKVEMERGLS KETHASAPVK MLPTYVCATP DGTEKGDFLA LDLGGTNFRV
     LLVRVRNGKW GGVEMHNKIY AIPQEVMHGT GDELFDHIVQ CIADFLEYMG MKGVSLPLGF
     TFSFPCQQNS LDESILLKWT KGFKASGCEG EDVVTLLKEA IHRREEFDLD VVAVVNDTVG
     TMMTCGFEDP HCEVGLIVGT GSNACYMEEM RNVELVEGEE GRMCVNMEWG AFGDNGCLDD
     FRTEFDVAVD ELSLNPGKQR FEKMISGMYL GEIVRNILID FTKRGLLFRG RISERLKTRG
     IFETKFLSQI ESDCLALLQV RAILQHLGLE STCDDSIIVK EVCTVVARRA AQLCGAGMAA
     VVDRIRENRG LDALKVTVGV DGTLYKLHPH FAKVMHETVK DLAPKCDVSF LQSEDGSGKG
     AALITAVACR IREAGQR
//
